Cite
HARVARD Citation
Niemann, C. et al. (2022). COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study. HemaSphere. 6 (10), pp. e780-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Niemann, C. et al. (2022). COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study. HemaSphere. 6 (10), pp. e780-. [Online].